Skip to main content
Clinical Trials/NCT05479201
NCT05479201
Completed
Not Applicable

Prevalence of Obstructive Sleep Apnoea (OSA) Among 4-8 Years Old Children in the General Population

Akureyri Hospital1 site in 1 country386 target enrollmentAugust 5, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obstructive Sleep Apnea (OSA)
Sponsor
Akureyri Hospital
Enrollment
386
Locations
1
Primary Endpoint
Prevalence of OSA in 4-8 year old children
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to estimated prevalence of obstructive sleep apnea (OSA) in 4-8 year old children. To date, most studies estimating prevalence of sleep apnea in young children are based on utilizing subjective questionnaires. The few studies that have utilized objective sleep measures have tested only those children suspected of sleep apnea based on subjective questionnaires, finding prevalence in the range of 1-13%. Untreated OSA is associated with significant morbidities in children, affecting their behavior, cognitive development, cardiovascular-and cardio metabolic health, endocrine and immune function. Better understanding of prevalence of sleep apnea in young children should be beneficial. This study will help to understand the prevalence of sleep apnea in each age-group of children 4-8 years of age and whether certain groups, such as children with obesity or asthma have higher prevalence and/or more severe disease.

The primary objective of this study is to get better understanding of prevalence and severity of sleep apnea in young children using objective sleep measures for all participants.

Detailed Description

The study is a population-based, observational study of 4-8 year old children located in Akureyri, Iceland. All parents in this geographical area will be invited for their child/children to participate in the study. Parents of all participating children will be asked to answer questionnaires to assess general health, sleep habits, behavior and quality of life and then measure their sleep for five consecutive nights with a home based sleep test.

Registry
clinicaltrials.gov
Start Date
August 5, 2022
End Date
June 30, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Akureyri Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children 4-8-years old

Exclusion Criteria

  • Children with atrial fibrillation or ventricular trigemini

Outcomes

Primary Outcomes

Prevalence of OSA in 4-8 year old children

Time Frame: Baseline

Apnea Hypopnea Index (AHI)

Secondary Outcomes

  • Prevalence of OSA defined by a specific age range (4-5-year-old/5-6-year-old/6-7-year-old/7-8-year-old)(Baseline)

Study Sites (1)

Loading locations...

Similar Trials